Cognex AI Stock Analysis
Want to see CGNX full AI Analyst Report?
Cognex (CGNX) AI Stock Analysis
Cognex
(NASDAQ:CGNX)
CGNX scores well on financial resilience (strong balance sheet and cash generation) and is supported by a very upbeat earnings outlook with raised guidance and meaningful margin expansion. These positives are offset by weak technicals (price well below key moving averages with bearish momentum) and a less compelling valuation profile (P/E ~33 with a low dividend yield).
Cognex Key Performance Indicators (KPIs)
Revenue by GeographyShows how sales are split across regions such as North America, Europe, and Asia (including China), highlighting where Cognex earns most of its revenue. Useful for spotting dependence on specific markets, exposure to regional manufacturing slowdowns or trade risks, and opportunities in faster-growing geographies.
Cognex’s geographic mix is shifting: Americas and Greater China (with steady Other Asia) are now the engines of its record top-line and recent sequential strength, while Europe lags—driven by automotive weakness and procurement/timing effects. Management’s upgraded guidance explicitly relies on China/Americas momentum and cost/price actions to deliver outsized margin expansion, but monitor memory‑price headwinds and roughly $5M/quarter of planned portfolio exits that will blunt revenue comps and could amplify Q4 seasonality.
Cognex (CGNX) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $8.02B
- Dividend Yield
- 0.72%
- Average Volume (3M)
- 1.83M
- Price to Earnings (P/E)
- 33.1
- Beta (1Y)
- 1.22
- Revenue Growth
- 15.82%
- EPS Growth
- 121.72%
- Country
- US
- Employees
- 2,745
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Hardware, Equipment & Parts
Cognex Business Overview & Revenue Model
Company Description
Cognex Corporation specializes in machine vision technology, offering solutions that interpret and process visual data to streamline and automate production and logistics operations globally. Their advanced vision systems enable the automated manufac...
How the Company Makes Money
Cognex makes money primarily by selling machine vision and identification hardware and associated software that customers integrate into production lines and logistics workflows. Key revenue streams include: (1) Machine vision products (e.g., vision...
Cognex Earnings Call Summary
The call was strongly positive. Cognex reported record revenue, significant margin expansion, record adjusted EPS, strong free cash flow, broad-based end-market growth, and raised full-year guidance. The company also highlighted strategic progress in AI, logistics, customer acquisition, and the pending RealSense acquisition. The main challenges were European and automotive weakness, expected seasonal Q4 moderation, comparison headwinds, lower investment income, and the remaining execution requirements for RealSense, but these were outweighed by the reported operating performance and outlook.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Excluding RealSense, Cognex expects fourth-quarter 2026 revenue of $270 million-$290 million, representing approximately 11% growth at the midpoint; adjusted EBITDA margin of 29%-32%, with the midpoint representing approximately 780 basis points of year-over-year expansion and approximately 100% revenue flow-through to adjusted EBITDA; and adjusted earnings per share of $0.37-$0.41, with the midpoint representing approximately 44% year-over-year growth. For full-year 2026, also excluding RealSense, the company expects revenue of $1.14 billion-$1.16 billion, representing approximately 16% growth at the midpoint, or 17% growth excluding the 2025 commercial partnership benefit; adjusted EBITDA margin of 31%-32%, representing approximately 1,000 basis points of year-over-year expansion, or approximately 1,080 basis points excluding the commercial partnership benefit; approximately $35 million of annualized net cost reductions, normalized for incentive compensation; approximately 93% flow-through of incremental revenue to adjusted EBITDA versus roughly 70% in 2025; and adjusted EPS of $1.68-$1.72, with the midpoint representing approximately 67% year-over-year growth, or 75% growth excluding the commercial partnership benefit, including approximately $0.08 per share of investment income versus the prior expectation of approximately $0.11 per share. Full-year end-market guidance includes double-digit growth across nearly all end markets, double-digit growth in logistics, packaging, and electronics, flat to low single-digit growth in automotive, and strong double-digit growth in semiconductor; for 2027, Dennis said flow-through may be around the 60% or so and “wouldn't put it as high as 90%,” while Matt said there were no concrete growth projections.
Cognex Financial Statement Overview
Summary
High-quality financial profile supported by a very strong balance sheet (very low leverage; ~0.04 debt-to-equity) and solid, improving cash generation (TTM FCF ~$286M; ~97% of net income). Profitability is strong (TTM ~69.7% gross margin, ~21.5% net margin), but the score is held back by uneven multi-year revenue trajectory and some historical margin/cash-flow coverage volatility.
Income Statement
76PositiveBalance Sheet
90Very PositiveCash Flow
84Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.13B | 994.36M | 914.51M | 837.55M | 1.01B | 1.04B |
| Gross Profit | 784.36M | 665.39M | 625.79M | 601.24M | 721.90M | 759.83M |
| EBITDA | 312.30M | 213.59M | 164.18M | 144.58M | 288.29M | 339.18M |
| Net Income | 241.94M | 114.44M | 106.17M | 113.23M | 215.53M | 279.88M |
Balance Sheet | ||||||
| Total Assets | 2.28B | 2.02B | 1.99B | 2.02B | 1.96B | 2.00B |
| Cash, Cash Equivalents and Short-Term Investments | 695.69M | 336.96M | 246.05M | 332.05M | 400.13M | 323.62M |
| Total Debt | 70.36M | 76.59M | 70.22M | 78.60M | 39.75M | 25.58M |
| Total Liabilities | 554.98M | 524.65M | 475.35M | 513.06M | 519.75M | 573.57M |
| Stockholders Equity | 1.72B | 1.49B | 1.52B | 1.50B | 1.44B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | 286.04M | 236.77M | 134.04M | 89.84M | 223.74M | 298.61M |
| Operating Cash Flow | 295.56M | 245.51M | 149.08M | 112.92M | 243.41M | 314.06M |
| Investing Cash Flow | 202.40M | 28.02M | -38.97M | 32.27M | -4.45M | -252.54M |
| Financing Cash Flow | -49.16M | -206.69M | -118.42M | -125.61M | -240.37M | -141.62M |
Cognex Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CGNX, the sentiment is Negative. The current price of 44.36 is below the 20-day moving average (MA) of 52.55, below the 50-day MA of 56.89, and below the 200-day MA of 58.44, indicating a bearish trend. The MACD of -2.63 indicates Positive momentum. The RSI at 35.96 is Neutral, neither overbought nor oversold. The STOCH value of 17.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CGNX.
Cognex Risk Analysis
Cognex disclosed 28 risk factors in its most recent earnings report. Cognex reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksCognex Peers Comparison
Overall Rating
TDY77Outperform
FTV73Outperform
CGNX73Outperform
OSIS68Neutral
NOVT62Neutral
TRMB60Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | $28.63B | 28.42 | 9.49% | ― | 8.43% | 26.65% | |
| 73Outperform | $19.47B | 30.85 | 10.62% | 0.47% | -22.06% | 19.92% | |
| 73Outperform | $8.02B | 33.10 | 15.31% | 0.72% | 15.82% | 121.72% | |
| 68Neutral | $3.08B | 20.47 | 18.92% | ― | 2.91% | 6.65% | |
| 62Neutral | $4.34B | 85.73 | 3.62% | ― | 13.18% | -9.22% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 60Neutral | $11.92B | -75.35 | -2.91% | ― | 6.88% | -146.42% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CGNX | Cognex | 44.36 | 7.46 | 20.23% | |
| NOVT | Novanta | 101.99 | -6.75 | -6.21% | |
| OSIS | OSI Systems | 187.00 | -69.34 | -27.05% | |
| TDY | Teledyne | 598.56 | 106.21 | 21.57% | |
| TRMB | Trimble Inc. | 50.62 | -28.44 | -35.97% | |
| FTV | Fortive | 64.16 | 11.93 | 22.85% |
Cognex Corporate Events
Cognex Reports Record Third-Quarter Results and RealSense Acquisition
PositiveOn November 4, 2026, Cognex reported record third-quarter revenue of $313 million for the period ended October 4, up 13% year over year, while adjusted EBITDA margin rose to 35.5% and adjusted diluted EPS increased 61% to $0.53. Excluding a one-time...
Cognex to Acquire RealSense, Expanding Robotic Perception Capabilities
PositiveOn September 22, 2026, Cognex announced a definitive agreement to acquire RealSense, Inc., a market leader in depth-sensing cameras and robotic perception technology, in an all-cash transaction valued at about $500 million funded from Cognex’s existi...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026
